Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT04042402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-30
First Post:
2019-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long Term Extension Study in Patients With Primary Hyperoxaluria
Sponsor:
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2030-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-10
First Submit QC Date:
None
Study First Post Date:
2019-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-29
Last Update Post Date:
2025-05-30
Last Update Post Date Type:
ACTUAL